BioCardia is pursuing a two-pronged regulatory strategy in Q3/Q4 2025, seeking FDA approval for its Helix transendocardial delivery catheter...

Praxis Precision Medicines announced positive topline data from the Phase 2 RADIANT study of vormatrigine in focal onset seizures....

Cassava Sciences reports positive preclinical data for simufilam in a tuberous sclerosis complex (TSC) mouse model, specifically demonstrating anti-seizure...

Microbiotica has completed patient enrollment in its Phase 1b COMPOSER-1 trial of MB310, a live biotherapeutic product (LBP) for...

In this interview, we sit down with Jane Myles and Joe Dustin, leaders in clinical operations and digital transformation...

Allogene Therapeutics has discontinued the fludarabine, cyclophosphamide, and ALLO-647 (FCA) arm of its pivotal ALPHA3 study in first-line large...

Artelo Biosciences has received positive scientific advice from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its...

BioXcel Therapeutics has completed the last patient visit in its pivotal Phase 3 SERENITY At-Home trial of BXCL501 (dexmedetomidine)...

Orchestra BioMed (OBIO) has secured $70 million in new funding from Ligand Pharmaceuticals and existing partner Medtronic, bolstering its...

Supernus Pharmaceuticals has completed its acquisition of Sage Therapeutics. The deal brings Sage’s recently approved postpartum depression (PPD) drug,...